| 000 | 01776 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250514020454.0 | ||
| 264 | 0 | _c20020125 | |
| 008 | 200201s 0 0 eng d | ||
| 022 | _a1524-4628 | ||
| 024 | 7 |
_a10.1161/hs1201.099663 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSterzer, P | |
| 245 | 0 | 0 |
_aPravastatin improves cerebral vasomotor reactivity in patients with subcortical small-vessel disease. _h[electronic resource] |
| 260 |
_bStroke _cDec 2001 |
||
| 300 |
_a2817-20 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAcetazolamide |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBlood Flow Velocity _xdrug effects |
| 650 | 0 | 4 |
_aCholesterol, LDL _xblood |
| 650 | 0 | 4 |
_aCognition Disorders _xdiagnosis |
| 650 | 0 | 4 |
_aDementia, Vascular _xdrug therapy |
| 650 | 0 | 4 |
_aEpilepsy _xdiagnosis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGait Disorders, Neurologic _xdiagnosis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aIschemic Attack, Transient _xdiagnosis |
| 650 | 0 | 4 | _aLinear Models |
| 650 | 0 | 4 | _aMagnetic Resonance Imaging |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPilot Projects |
| 650 | 0 | 4 |
_aPravastatin _xtherapeutic use |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aSubtraction Technique |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aUltrasonography, Doppler, Transcranial |
| 650 | 0 | 4 |
_aVasomotor System _xdrug effects |
| 700 | 1 | _aMeintzschel, F | |
| 700 | 1 | _aRösler, A | |
| 700 | 1 | _aLanfermann, H | |
| 700 | 1 | _aSteinmetz, H | |
| 700 | 1 | _aSitzer, M | |
| 773 | 0 |
_tStroke _gvol. 32 _gno. 12 _gp. 2817-20 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/hs1201.099663 _zAvailable from publisher's website |
| 999 |
_c11653263 _d11653263 |
||